Corpus ID: 32027651

Outside the Black Box: Re-assessing Pediatric Antidepressant Prescription.

@article{Sparks2013OutsideTB,
  title={Outside the Black Box: Re-assessing Pediatric Antidepressant Prescription.},
  author={J. Sparks and B. Duncan},
  journal={Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent},
  year={2013},
  volume={22 3},
  pages={
          240-6
        }
}
  • J. Sparks, B. Duncan
  • Published 2013
  • Medicine
  • Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent
  • OBJECTIVE The purpose of this review is to assess whether evidence supports a favorable risk/benefit profile for pediatric antidepressant use and reconsideration of the black box. METHOD The review examines studies post-black box purporting to show declines in pediatric antidepressant use and rising youth suicide, summarizes evidence for efficacy and safety of pediatric antidepressants, and discusses irregularities in recent meta-analyses of fluoxetine for youth. RESULTS Pediatric… CONTINUE READING
    19 Citations

    Figures and Topics from this paper

    Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified
    • 10
    • PDF
    Antidepressant drug treatment in Child and adolescent Psychiatry
    • PDF
    The treatment of major depression with fluoxetine
    • PDF
    Present and future of developmental neuropsychopharmacology
    • C. Arango
    • Psychology, Medicine
    • European Neuropsychopharmacology
    • 2015
    • 13
    Psychiatric Drugging of Children and Youth as a Form of Child Abuse: Not a Radical Proposition
    • B. Burstow
    • Psychology
    • Ethical Human Psychology and Psychiatry
    • 2017
    • 5

    References

    SHOWING 1-10 OF 49 REFERENCES
    How do we Safely Treat Depression in Children, Adolescents and Young Adults?
    • 5
    Efficacy and safety of antidepressants for children and adolescents
    • 295
    • PDF
    Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs.
    • 254
    • Highly Influential
    Efficacy of antidepressants in juvenile depression: meta-analysis
    • 138
    • PDF
    Suicidality in pediatric patients treated with antidepressant drugs.
    • 884
    • PDF
    Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
    • 163
    • PDF
    Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine.
    • 159
    • PDF